Provided by Tiger Trade Technology Pte. Ltd.

MDA Space Ltd.

28.67
-0.2150-0.74%
Volume:123.48K
Turnover:3.55M
Market Cap:4.64B
PE:51.36
High:29.03
Open:28.82
Low:28.63
Close:28.88
52wk High:49.37
52wk Low:15.00
Shares:162.00M
Float Shares:160.00M
Volume Ratio:0.39
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5582
EPS(LYR):0.6126
ROE:6.68%
ROA:2.75%
PB:3.41
PE(LYR):46.79

Loading ...

MDA Space Launches Venture Unit to Fund Domestic Defense Tech

Dow Jones
·
Aug 27

MDA Space is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 20

MDA Space price target raised to $50 from $43 at JPMorgan

TIPRANKS
·
Aug 19

MDA Space Ltd : JP Morgan Raises Target Price to $50 from $43

THOMSON REUTERS
·
Aug 19

MDA Space Valuation Attractive Amid Space Economy Exposure, RBC Says

MT Newswires Live
·
Aug 17

MDA Space Price Target Maintained with a $60.00/Share by RBC Capital

Dow Jones
·
Aug 17

MDA Space Ltd (MDA) Receives a Buy from Morgan Stanley

TIPRANKS
·
Aug 17

MDA Space Delivers First Satellites as Prime Contractor for Commercial Fleet

Dow Jones
·
Aug 17

MDA Space confirms deployment of satellites for Globalstar’s LEO constellation

TIPRANKS
·
Aug 17

Command centre in Quebec unveiled as Canadian-made satellite prepares to launch

Bloomberg
·
Aug 12

MDA Space Posts Strong Q2 as Contracts, Acquisitions Support Growth, RBC Capital Markets Says

MT Newswires Live
·
Aug 11

MDA Space Ltd (MDA) Gets a Buy from CIBC

TIPRANKS
·
Aug 10

Kratos Defense announces role in Missile Defense Agency joint flight experiment

TIPRANKS
·
Aug 10

Kratos Target Systems Utilized During Successful MDA-Joint Flight Test Experiment-01 Mission

GlobeNewswire
·
Aug 10

Scotiabank Reaffirms Their Buy Rating on MDA Space Ltd (MDA)

TIPRANKS
·
Aug 10

Deutsche Bank Adjusts MDA Space Price Target to $41 From $40, Maintains Buy Rating

MT Newswires Live
·
Aug 10

RBC Adjusts Price Target on MDA Space to CA$60 From CA$58, Maintains Outperform Rating

MT Newswires Live
·
Aug 10

Press Release: MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across All Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 10

MDA Ltd. Earnings Call Signals High-Growth Space Ambitions

TIPRANKS
·
Aug 08

MDA Space PT Raised to C$70 on Strong Q2 Beat, Upgraded Outlook and Robust Backlog

TIPRANKS
·
Aug 08